Literature DB >> 1959794

The epidemiology of ovarian cancer.

F Parazzini1, S Franceschi, C La Vecchia, M Fasoli.   

Abstract

The descriptive and analytical epidemiology of ovarian cancer is reviewed, starting from the substantial geographical differences, with high rates in North America and Europe and low rates in developing countries and Japan, although, on a worldwide scale, almost 50% of 140,000 total cases occur in developing countries. Over the past decades, incidence and mortality rates have remained approximately stable in high-risk areas, but have generally tended to rise in low-risk areas. In the past, ovarian cancer was more common in higher social classes, but sociocultural differences seem to have flattened off over recent decades. In etiological terms, the protection afforded by multiparity and oral contraceptive (OC) use is well established, with relative risks (RRs) of the order of 0.5 for multiparae and OC users. There is also consistent evidence that risk increases with late age at menopause. Less consistent and weak, if any, are the effects of age at menarche and first birth, although there is hint that a first birth over age 35 is not protective. It is conceivable that diet can play an important role in ovarian carcinogenesis, but only scattered data are available to suggest that high fat consumption may represent an indicator of risk. Available knowledge on ovarian cancer epidemiology is also discussed in relation to models of carcinogenesis and implications for prevention and public health.

Entities:  

Mesh:

Year:  1991        PMID: 1959794     DOI: 10.1016/0090-8258(91)90003-n

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

1.  Epidemiological characteristics of ovarian cancer in Korea.

Authors:  Boyoung Park; Sohee Park; Tae-Joong Kim; Seung Hyun Ma; Byoung-Gie Kim; Yong-Man Kim; Jae Weon Kim; Sokbom Kang; Jaehoon Kim; Tae Jin Kim; Keun-Young Yoo; Sue K Park
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

2.  Risk factors for seromucinous benign ovarian cysts in northern Italy.

Authors:  F Parazzini; S Moroni; E Negri; C La Vecchia; R Mezzopane; P G Crosignani
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 3.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89.

Authors:  F Jin; X O Shu; S S Devesa; W Zheng; W J Blot; Y T Gao
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

Review 5.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

Review 6.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

8.  Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study.

Authors:  Md Mobarak Hossain Khan; Aklimunnessa Khan; Masahiro Nojima; Sadao Suzuki; Yoshihisa Fujino; Shinkan Tokudome; Koji Tamakoshi; Mitsuru Mori; Akiko Tamakoshi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

Review 9.  The genetics of breast and ovarian cancer.

Authors:  D Ford; D F Easton
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

10.  Risk factors for benign ovarian teratomas.

Authors:  F Parazzini; C La Vecchia; E Negri; S Moroni; A Villa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.